Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Some breast cancer chemotherapy can cause permanent hair loss.

Different types of fibroblasts play various roles in kidney repair and aging, and may affect chronic kidney disease outcomes.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

TGF-β signaling is crucial for stem cell maintenance, differentiation, and has implications for cancer treatment.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Fibroblast growth factor receptor signaling controls cell development and repair, and its malfunction can cause disorders and cancer, but it also offers potential for targeted therapies.

PLD is an effective and safer alternative for treating breast cancer.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The p53 protein has complex, sometimes contradictory functions, including tumor suppression and promoting cell survival.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Male pattern baldness is mostly inherited, involves many genes, and is linked to other traits like early puberty and strong bones.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Hair and nail changes can indicate health issues, including cancer and side effects from cancer treatments.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.